H

Hugel Inc
KOSDAQ:145020

Watchlist Manager
Hugel Inc
KOSDAQ:145020
Watchlist
Price: 279 500 KRW -0.36% Market Closed
Market Cap: 3.5T KRW
Have any thoughts about
Hugel Inc?
Write Note

P/E
Price to Earnings

31.4
Current
25.6
Median
22.1
Industry
Higher than median
Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
31.4
=
Market Cap
3.5T KRW
/
Net Income
112B KRW
All Countries
Close
Earnings Growth P/E to Growth
KR
H
Hugel Inc
KOSDAQ:145020
Average P/E: 180.7
31.4
113%
0.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.4
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
910
77%
11.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -211.2
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -135.6 N/A N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
27
2-Years Forward
P/E
21.3
3-Years Forward
P/E
17.8

See Also

Discover More